ew treatment for fear of the future in MS patients
- Conditions
- Multiple Sclerosis / Multiple Sclerosefuture anxiety
- Registration Number
- NL-OMON28790
- Lead Sponsor
- Medical Center ETZ
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 52
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
ƒ{ diagnosis Multiple Sclerosis
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
ƒ{ severe psychiatric comorbidity; i.e. dissociation, high suicide risk
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary parameter: <br /><br>Anxiety scores on the hospital anxiety and depression scale (HADS-A).<br /><br>The HADS questionnaire is specially designed to measure mood disturbance in people with physical illness (Zigmond and Snaith 1983).
- Secondary Outcome Measures
Name Time Method Other parameters:<br /><br>- Penn State Worry Questionnaire (PSWQ) scores. The PSWQ is a diagnostic indicator of excessiveness and uncontrollability of worry in non-clinical populations and patient samples (van der Heiden, Muris et al. 2010). Although there is not a norm group specific for MS patients, the PSWQ is used to examine worry in MS (Thornton, Tedman et al. 2006).<br /><br>ƒ{ Scores on Quality of Life questionnaire: World Health Organisation Quality of Life (WHOQOL-bref). WHOQOL-bref is a solid, cross-cultural valid assessment of Quality of Life, reflected in four domains; physical, psychological, social and environment (Skevington et al., 2004). Although there is not a norm group specific for MS patients, the WHOQoL was been used to examine quality of life in MS (Phillips, Saldias et al. 2009, Wynia, Middel et al. 2009).